https://doi.org/10.1200/jco.2007.14.8957
A
Antonino Musolino
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
358
Papers
5.1K
Citations
34
h-index
78
i10-index
Antonino Musolino is an academic researcher from University of Milan. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & BRCA gene mutations in cancer. The author has an h-index of 34, co-authored 305 publications.
ORCID: 0000-0002-7979-6261Papers by this author
worksImmunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ <i>neu</i> –Positive Metastatic Breast Cancer
2008 · Journal of Clinical Oncology · 950 citations
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
2012 · Journal of Clinical Oncology · 366 citations
https://doi.org/10.1200/jco.2011.39.0823
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
2021 · JAMA Oncology · 336 citations
https://doi.org/10.1001/jamaoncol.2020.7932
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study
2018 · Annals of Oncology · 152 citations
https://doi.org/10.1093/annonc/mdy414
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study
2007 · The Breast · 131 citations
https://doi.org/10.1016/j.breast.2006.12.003
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy
2017 · Breast Cancer Research · 115 citations
https://doi.org/10.1186/s13058-017-0807-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat